Inicio › Enfermedad de obstrucción pulmonar crónica › Ohio
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Ohio
16 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50003, Columbus
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07725939Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Dayton Clinical Research- Site Number : 8400124, Dayton
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07190209Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Asthma & Allergy Center - Toledo- Site Number : 8400110, Toledo
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Cleveland
- Research Site, Marion
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Columbus
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Toledo Institute of Clinical Research Inc., Toledo
ReclutandoFase 2/3
Edades de 35 a 80 · Todos los sexos · Actualizado el 31 ago 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Blue Ash
- Research Site, Columbus
- Research Site, Marion
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 26 ago 2026 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 104, Cleveland
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 ago 2026 · NCT07555483To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Remington-Davis Research, Columbus
ReclutandoFase 2
Edades de 40 a 85 · Todos los sexos · Actualizado el 7 ago 2026 · NCT07684820Multi-Center Clean Air Randomized Controlled Trial in COPD
- Cleveland Clinic, Cleveland
ReclutandoFase 3
Edades de 40 en adelante · Todos los sexos · Actualizado el 31 jul 2026 · NCT06376994PEP Buddy in Pulmonary Rehabilitation
- Cincinnati VA Medical Center, Cincinnati, OH, Cincinnati
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Reclutando
Edades de 40 a 89 · Todos los sexos · Actualizado el 24 jul 2026 · NCT07404826Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Ohio State University Medical Center - Ohio State Lung Center, Columbus
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 28 abr 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Cleveland Clinic Foundation, Cleveland
- The Ohio State University, Columbus
Reclutando
Edades de 40 a 84 · Todos los sexos · Actualizado el 24 abr 2026 · NCT06891755Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
- Cleveland Clinic Foundation, Cleveland
Reclutando
Edades de 40 en adelante · Todos los sexos · Actualizado el 30 oct 2025 · NCT07059637myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Cincinnati VA Medical Center, Cincinnati
- Cleveland Clinic Foundation, Cleveland
- Ohio State University Wexner Medical Center, Columbus
Reclutando
Edades de 30 en adelante · Todos los sexos · Actualizado el 6 feb 2025 · NCT05204888PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- MetroHealth, Cleveland
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 oct 2023 · NCT05306743De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.